Literature DB >> 25817514

Morphologic changes in the mesolimbic pathway in Parkinson's disease motor subtypes.

Eric M Nyberg1, Jody Tanabe1, Justin M Honce1, Theodore Krmpotich1, Erika Shelton2, Jessica Hedeman2, Brian D Berman3.   

Abstract

BACKGROUND: Parkinson's disease (PD) is a common neurodegenerative disorder associated with gray matter atrophy. Cortical atrophy patterns may further help distinguish between PD motor subtypes. Comparable differences in subcortical volumes have not been found.
METHODS: Twenty-one cognitively intact and treated PD patients, including 12 tremor dominant (TD) subtype, Nine postural instability gait dominant (PIGD) subtype, and 20 matched healthy control subjects underwent 3.0 T high-resolution structural MRI scanning. Subcortical volumetric analysis was performed using FreeSurfer and shape analysis was performed with FIRST to assess for differences between PD patients and controls and between PD subtypes.
RESULTS: No significant differences in subcortical volumes were found between motor PD subtypes, but comparing grouped PD patients with controls revealed a significant increase in hippocampal volume in PD patients (p = 0.03). A significant shape difference was detected in the right nucleus accumbens (NAcc) between PD and controls and between motor subtypes. Shape differences were driven by positive deviations in the TD subtype. Correlation analysis revealed a trend between hippocampal volume and decreasing MDS-UPDRS (p = 0.06).
CONCLUSION: While no significant differences in subcortical volumes between PD motor subtypes were found, increased hippocampal volumes were observed in PD patients compared to controls. Right NAcc shape differences in PD patients were driven by changes in the TD subtype. These unexpected findings may be related to the effects of chronic dopaminergic replacement on the mesolimbic pathway. Further studies are needed to replicate and determine the clinical significance of such morphologic changes.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dopamine; Hippocampus; Nucleus accumbens; Parkinson's disease; Shape analysis; Volumetric analysis

Mesh:

Year:  2015        PMID: 25817514      PMCID: PMC4424152          DOI: 10.1016/j.parkreldis.2015.03.008

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  16 in total

1.  Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.

Authors:  R Swainson; R D Rogers; B J Sahakian; B A Summers; C E Polkey; T W Robbins
Journal:  Neuropsychologia       Date:  2000       Impact factor: 3.139

2.  A clinico-pathological study of subtypes in Parkinson's disease.

Authors:  M Selikhova; D R Williams; P A Kempster; J L Holton; T Revesz; A J Lees
Journal:  Brain       Date:  2009-09-16       Impact factor: 13.501

3.  Akinetic-rigid and tremor-dominant Parkinson's disease patients show different patterns of FP-CIT single photon emission computed tomography.

Authors:  Carsten Eggers; Deniz Kahraman; Gereon R Fink; Matthias Schmidt; Lars Timmermann
Journal:  Mov Disord       Date:  2011-01-24       Impact factor: 10.338

4.  Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease.

Authors:  Nagaendran Kandiah; Nur Hani Zainal; Kaavya Narasimhalu; Russell Jude Chander; Aloysius Ng; Elijah Mak; Wing Lok Au; Yih Yian Sitoh; Nivedita Nadkarni; Louis C S Tan
Journal:  Parkinsonism Relat Disord       Date:  2014-09-16       Impact factor: 4.891

5.  Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies.

Authors:  D J Burn; E N Rowan; L M Allan; S Molloy; J T O'Brien; I G McKeith
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05       Impact factor: 10.154

6.  Parkinson's disease and local atrophy in subcortical nuclei: insight from shape analysis.

Authors:  Federico Nemmi; Umberto Sabatini; Olivier Rascol; Patrice Péran
Journal:  Neurobiol Aging       Date:  2014-07-23       Impact factor: 4.673

7.  Degenerative changes were common in brain magnetic resonance imaging in patients with newly diagnosed Parkinson's disease in a population-based cohort.

Authors:  Jan Linder; Richard Birgander; Ingegerd Olsson; Katrine Riklund; Ann-Katrine Larsson; Mona Edström; Hans Stenlund; Lars Forsgren
Journal:  J Neurol       Date:  2009-05-31       Impact factor: 4.849

8.  Subcortical grey matter changes in untreated, early stage Parkinson's disease without dementia.

Authors:  Hye Mi Lee; Kyum-Yil Kwon; Min-Jik Kim; Ji-Wan Jang; Sang-Il Suh; Seong-Beom Koh; Ji Hyun Kim
Journal:  Parkinsonism Relat Disord       Date:  2014-03-20       Impact factor: 4.891

9.  Gray matter atrophy distinguishes between Parkinson disease motor subtypes.

Authors:  Keren Rosenberg-Katz; Talia Herman; Yael Jacob; Nir Giladi; Talma Hendler; Jeffrey M Hausdorff
Journal:  Neurology       Date:  2013-03-20       Impact factor: 9.910

10.  Comprehensive morphometry of subcortical grey matter structures in early-stage Parkinson's disease.

Authors:  Ricarda A L Menke; Konrad Szewczyk-Krolikowski; Saad Jbabdi; Mark Jenkinson; Kevin Talbot; Clare E Mackay; Michele Hu
Journal:  Hum Brain Mapp       Date:  2013-07-16       Impact factor: 5.038

View more
  10 in total

Review 1.  Balance and the brain: A review of structural brain correlates of postural balance and balance training in humans.

Authors:  Olivia J Surgent; Olga I Dadalko; Kristen A Pickett; Brittany G Travers
Journal:  Gait Posture       Date:  2019-05-06       Impact factor: 2.840

Review 2.  Structural Imaging in Parkinson's Disease: New Developments.

Authors:  Stéphane Prange; Elise Metereau; Stéphane Thobois
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-18       Impact factor: 5.081

Review 3.  Nucleus accumbens atrophy in Parkinson's disease (Mavridis' atrophy): 10 years later.

Authors:  Ioannis N Mavridis; Efstratios-Stylianos Pyrgelis
Journal:  Am J Neurodegener Dis       Date:  2022-06-20

4.  Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease.

Authors:  Nathan A Holtz; Stephanie E Tedford; Amanda L Persons; Salvatore A Grasso; T Celeste Napier
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-05-20       Impact factor: 5.067

5.  Striatal and Hippocampal Atrophy in Idiopathic Parkinson's Disease Patients without Dementia: A Morphometric Analysis.

Authors:  Jared J Tanner; Nikolaus R McFarland; Catherine C Price
Journal:  Front Neurol       Date:  2017-04-13       Impact factor: 4.003

6.  Differentiating Parkinson's disease motor subtypes using automated volume-based morphometry incorporating white matter and deep gray nuclear lesion load.

Authors:  Eric Fang; Chu Ning Ann; Bénédicte Maréchal; Jie Xin Lim; Shawn Yan Zhi Tan; Huihua Li; Julian Gan; Eng King Tan; Ling Ling Chan
Journal:  J Magn Reson Imaging       Date:  2019-07-31       Impact factor: 4.813

Review 7.  Neuroimaging Detectable Differences between Parkinson's Disease Motor Subtypes: A Systematic Review.

Authors:  Jackson Tyler Boonstra; Stijn Michielse; Yasin Temel; Govert Hoogland; Ali Jahanshahi
Journal:  Mov Disord Clin Pract       Date:  2020-11-06

Review 8.  Nigral neuropathology of Parkinson's motor subtypes coincide with circuitopathies: a scoping review.

Authors:  Jackson Tyler Boonstra; Hugo McGurran; Yasin Temel; Ali Jahanshahi
Journal:  Brain Struct Funct       Date:  2022-07-19       Impact factor: 3.748

9.  Subcortical Volumes Differ in Parkinson's Disease Motor Subtypes: New Insights into the Pathophysiology of Disparate Symptoms.

Authors:  Keren Rosenberg-Katz; Talia Herman; Yael Jacob; Efrat Kliper; Nir Giladi; Jeffery M Hausdorff
Journal:  Front Hum Neurosci       Date:  2016-07-11       Impact factor: 3.169

10.  Structural Brain Alterations in Motor Subtypes of Parkinson's Disease: Evidence from Probabilistic Tractography and Shape Analysis.

Authors:  Griet Vervoort; Inge Leunissen; Michael Firbank; Elke Heremans; Evelien Nackaerts; Wim Vandenberghe; Alice Nieuwboer
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.